Endothelial Cell Gene Networks of CVD
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- Tufts Medical Center - Cardiovascular Clinic
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria for CVD subjects::
• >50% stenosis of one or more coronary arteries
Inclusion Criteria for Healthy subjects:
• absence of coronary artery stenosis
Exclusion Criteria for all subjects:
- type 2 diabetes mellitus
- chronic kidney disease,
- other chronic diseases
- dyslipidemia (fasting plasma LDL-C >160 mg/dL and triglyceride levels >150 mg/dL)
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
CVD subjects
CVD will be defined as >50% stenosis of one or more coronary arteries as assessed by coronary angiography.
|
Circulating endothelial precursor cells will be isolated and then cultured in vitro.
RNA will be then isolated.
|
|
healthy controls
healthy controls defined as not having stenosis of coronary arteries as assessed by coronary angiography.
|
Circulating endothelial precursor cells will be isolated and then cultured in vitro.
RNA will be then isolated.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gene expression
Time Frame: 10 weeks
|
Gene expression [ identify relevant signature gene networks of cardiovascular disease in endothelial cells]
|
10 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Stefania Lamon-Fava, PhD, Tufts University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 12841
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.